Phase II study of sorafenib (BAY 43-9006) in combination with gemcitabine in recurrent epithelial ovarian cancer: A study of the PMH phase II consortium. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Welch, S
  • Hirte, H
  • Schilder, R
  • Townsley, C
  • Tinker, L
  • Pond, Gregory
  • Afinec, A
  • Wright, J
  • Oza, A

publication date

  • December 15, 2005